Literature DB >> 8764002

Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein.

A Rein1, D E Ott, J Mirro, L O Arthur, W Rice, L E Henderson.   

Abstract

All retroviral nucleocapsid (NC) proteins, except those of spumaretroviruses, contain one or two copies of the conserved sequence motif C-X2-C-X4-H-X4-C. The conserved cysteine and histidine residues coordinate a zinc ion in each such motif. Rice et al. (W. G. Rice, J. G. Supko, L. Malspeis, R. W. Buckheit, Jr., D. Clanton, M. Bu, L. Graham, C. A. Schaeffer, J. A. Turpin, J. Domagala, R. Gogliotti, J. P. Bader, S. M. Halliday, L. Coren, R. C. Sowder II, L. 0. Arthur, and L. E. Henderson, Science 270:1194-1197, 1995) have described a series of compounds which inactivate human immunodeficiency virus type 1 (HIV-1) particles and oxidize the cysteine thiolates in the NC zinc finger. We have characterized the effects of three such compounds on Moloney murine leukemia virus (MuLV). We find that, as with HIV-1, the compounds inactivate cell-free MuLV particles and induce disulfide cross-linking of NC in these particles. The killed MuLV particles were found to be incapable of synthesizing full-length viral DNA upon infection of a new host cell. When MuLV particles are synthesized in the presence of one of these compounds, the normal maturational cleavage of the Gag polyprotein does not occur. The compounds have no effect on the infectivity of human foamy virus, a spumaretrovirus lacking zinc fingers in its NC protein. The resistance of foamy virus supports the hypothesis that the zinc fingers are the targets for inactivation of MuLV and HIV- I by the compounds. The absolute conservation of the zinc finger motif among oncoretroviruses and lentiviruses and the lethality of all known mutations altering the zinc-binding residues suggest that only the normal, wild-type structure can efficiently perform all of its functions. This possibility would make the zinc finger an ideal target for antiretroviral agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764002      PMCID: PMC190449     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.

Authors:  A Aldovini; R A Young
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA.

Authors:  R J Gorelick; D J Chabot; D E Ott; T D Gagliardi; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  The preparation and biochemical characterization of intact capsids of equine infectious anemia virus.

Authors:  M M Roberts; S Oroszlan
Journal:  Biochem Biophys Res Commun       Date:  1989-04-28       Impact factor: 3.575

4.  Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein.

Authors:  C Méric; S P Goff
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

5.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

6.  Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses.

Authors:  R J Versteegen; S Oroszlan
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

7.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

Review 8.  The glutathione status of cells.

Authors:  N S Kosower; E M Kosower
Journal:  Int Rev Cytol       Date:  1978

9.  Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence.

Authors:  R J Gorelick; L E Henderson; J P Hanser; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus.

Authors:  B Maurer; H Bannert; G Darai; R M Flügel
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  16 in total

1.  Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design.

Authors:  I A Topol; C McGrath; E Chertova; C Dasenbrock; W R Lacourse; M A Eissenstat; S K Burt; L E Henderson; J R Casas-Finet
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

2.  Reversal by dithiothreitol treatment of the block in murine leukemia virus maturation induced by disulfide cross-linking.

Authors:  Stephen Campbell; Masamichi Oshima; Jane Mirro; Kunio Nagashima; Alan Rein
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome.

Authors:  Cristina Gherghe; Tania Lombo; Christopher W Leonard; Siddhartha A K Datta; Julian W Bess; Robert J Gorelick; Alan Rein; Kevin M Weeks
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

4.  Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.

Authors:  J L Rossio; M T Esser; K Suryanarayana; D K Schneider; J W Bess; G M Vasquez; T A Wiltrout; E Chertova; M K Grimes; Q Sattentau; L O Arthur; L E Henderson; J D Lifson
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope.

Authors:  Yossef Raviv; Mathias Viard; Julian W Bess; Elena Chertova; Robert Blumenthal
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Arenavirus Z protein as an antiviral target: virus inactivation and protein oligomerization by zinc finger-reactive compounds.

Authors:  Cybele C García; Mahmoud Djavani; Ivan Topisirovic; Katherine L B Borden; María S Salvato; Elsa B Damonte
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

7.  Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles.

Authors:  J A Turpin; S J Terpening; C A Schaeffer; G Yu; C J Glover; R L Felsted; E A Sausville; W G Rice
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  Effects of blocking individual maturation cleavages in murine leukemia virus gag.

Authors:  Masamichi Oshima; Delphine Muriaux; Jane Mirro; Kunio Nagashima; Kelly Dryden; Mark Yeager; Alan Rein
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  HIV-1 inactivation by 4-vinylpyridine is enhanced by dissociating Zn(2+) from nucleocapsid protein.

Authors:  David R Morcock; James A Thomas; Raymond C Sowder; Louis E Henderson; Bruce J Crise; Robert J Gorelick
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

10.  Inactivation of respiratory syncytial virus by zinc finger reactive compounds.

Authors:  Marina S Boukhvalova; Gregory A Prince; Jorge C G Blanco
Journal:  Virol J       Date:  2010-01-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.